What maintains or regenerates a chronic pattern?
The maintained feature might be continuous pathology. It might instead involve altered threshold, response size, recovery, recurrence, learning, exposure, treatment, or several processes at once.
Continuing project · dynamic measurement
A symptom score or resting biomarker can show that something differs. It usually cannot show what produced the difference, how long it lasts, or where in the course of chronic pain and illness the change occurred.
This project follows inputs, responses, recovery, recurrence, and longer-term outcomes so that competing explanations can be compared.
Conceptual response profile
Follow a practice from its actual dose and timing to immediate and delayed outcomes. The methods below separate symptoms, function, physiology and disease activity, compare rival explanations, and include burden, nonresponse and harms.
Page updated 28 September 2026 · Measurement project
Two linked questions
The maintained feature might be continuous pathology. It might instead involve altered threshold, response size, recovery, recurrence, learning, exposure, treatment, or several processes at once.
A practice may change experience, interpretation, behavior, exposure, physiology, function, disease activity, or none of them. Those are different findings.
The lived intervention
Programs such as Primal Trust and Somia do not deliver one isolated technique. They teach people how to notice and interpret symptoms, direct attention, regulate arousal, choose activity or rest, engage with care, and repeat those responses inside a relationship and explanatory system.
“I feel steady enough to begin.”
Morning walk · after shortened sleep
Less catastrophizing could alter distress and action without changing pathology. Pacing could reduce exposure to a trigger. Continued activity could create useful learning or provoke delayed worsening. Relationship and explanation could increase expectancy and adherence. A symptom change cannot identify which route occurred, so the study must observe the instructions, the person’s response, and the downstream course.
Our proposed Program Observatory would extend the audits into participation: helping people follow what they encounter, understand and try, and return to their experience when deciding what comes next. With separate consent, those records could also improve the audits and inform more adaptable courses.
See the participant journey and an example record →The questions below connect that purpose to measurement. They distinguish what a course teaches from how someone receives it and what follows.
These connections are research questions. Someone can use a practice while questioning its story, and changes in health or circumstances can change what is possible. Accurate course descriptions, useful information and health effects each need their own evaluation.
These are possible interview prompts. A person could skip a question or correct our interpretation. Recording, access and reuse would need their own agreement; a private account would not become public by default.
Choose a question, a relevant observation window and what result could change a decision. Follow delayed costs as well as immediate effects, and consider other care, illness changes and circumstances that could explain the result.
Question wording, timing and repetition can themselves affect attention, experience and burden. There is no universal check-in schedule. Skipped responses remain missing; they do not mean good health or poor motivation. Any future study would need a tolerable schedule, easy pause and exit, and a way to assess the effects of monitoring itself.
Reading these resources does not require contributing health data. This section describes proposed research; it does not collect responses or offer symptom monitoring.
The measurement problem
A flare that settles after a practice is worth observing. On its own, that sequence does not identify the process that caused improvement.
Dynamic phenotype
Repeated observations can describe how a person or system responds across time. The features below help turn a broad account of “regulation” or “reset” into measurements that competing models can address.
A reproducible response profile can sharpen a hypothesis. It does not by itself establish an attractor, a mechanism, or a clinical indication.
Concrete observation
No study needs every item. The point is to select measures that can locate a proposed change and distinguish it from the most credible alternatives.
Outcome layers
Experience, behavior, physiology, and disease processes influence one another. They can also move differently.
A study should be able to show whether a practice changed pain, daily function, a physiological response, disease activity, treatment burden, or some combination of them.
What a person actually did, in what sequence, with what intensity and adherence.
Treatment, environment, relationship, explanation, expectation, activity, sleep, and other changing inputs.
Pain, fatigue, distress, bodily experience, agency, and other reported effects.
Movement, avoidance, participation, daily activity, work, and social function.
Autonomic, endocrine, sensory, motor, sleep, and other regulatory measures chosen for the question.
Immune activity, tissue state, exposure, infection, injury, or other disease-specific processes.
Disease activity, damage, treatment burden, adverse effects, durability, and longer-term change.
Study sequence
The sequence begins with observation and measurement quality. Later stages add intervention and prediction only when the question, population, and safeguards are defined.
State what is expected to change, what else could explain the observation, and what result would count against each account.
Follow flares, recoveries, ordinary practice, and relevant exposures before adding a study manipulation.
Establish whether the measures are feasible, repeatable, sensitive to change, and meaningful to participants.
Distinguish fast responses, slower regulatory configurations, stable person characteristics, and changing context.
Where clinically appropriate, use preauthorized challenges or practice sequences to reveal threshold, response, and recovery dynamics.
Measure actual dose, sequence, co-interventions, adherence, durability, nonresponse, adverse effects, and exit.
Evaluate selection rules and model predictions in new observations, new participants, or a held-out portion of the data.
Timescale
Attention, appraisal, breathing, autonomic activity, sensation, and the first behavioral choice.
Peak burden, delayed flare, symptom spread, sleep, function, medication use, decay, and recurrence.
Actual practice dose, changing exposure and activity, response parameters, generalization, relapse, disease activity, and harm.
Model comparison
Active inference and attractor language are useful only when they make better predictions than a simpler account.
Repeated response parameters, restoring tendencies, thresholds, path dependence, or timing effects predict new episodes and intervention effects better than simpler models.
Ongoing pathology, exposure, ordinary learning, treatment change, autoregression, or natural history explains the observations as well or better.
First study families
These studies can begin without assuming that chronic illness is one type of state or that every mind-body program works through the same mechanism.
Follow triggers, symptoms, physiology, function, treatment, and delayed recovery before imposing a challenge.
Observe participants before, during, and after the full multiweek dose, including practice, coaching, co-treatment, dropout, nonresponse, harm, and durability.
Compare attention, explanation, breathing, exposure, movement, relationship, and sequence under credible matched conditions.
Ask whether response parameters and context predict held-out episodes or treatment effects better than simpler pathology, exposure, learning, or natural-history models.
Decisions
A useful study could show whether a practice changes experience during practice, behavior and exposure, a repeatable response parameter, disease activity, the longer-term course of illness, or nothing measurable. It should also help identify for whom, at what dose and timescale, with what burden, and with what risk of harm.
Program architecture: Between Symptom and Disease: Measurement Roadmap. The multimodal pilot is an early feasibility example and does not establish clinical efficacy.